Patents
Patents for C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306)
07/2005
07/21/2005US20050159344 Forming a carboxy-saccharide derivative of the glycopeptide antibiotic that has a substituent containing a dicarboxylic acid in which one of the carboxylic acid groups is coupled with a saccharide
07/21/2005US20050159341 Scaffolded maleimide clusters for multivalent peptide assembly
07/19/2005US6919439 Derivatized oligonucleotides having improved uptake and other properties
07/14/2005WO2005063797A1 NONNATURAL C-LINKED CARBO-β-PEPTIDES WITH ROBUST SECONDARY STRUCTURES
07/06/2005CN1635901A Remodeling and glycoconjugation of peptides
07/05/2005US6914045 Glycopeptide antibiotics
06/2005
06/28/2005US6911318 Glucosamine pyrophosphates
06/23/2005WO2005056572A2 Clustered multi-antigenic carbohydrate constructs, methods for their preparation and uses thereof
06/16/2005WO2004111192A3 Targeted delivery to legumain-expressing cells
06/16/2005US20050131208 Method for producing a modified peptide
06/15/2005EP1539804A2 Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells
06/14/2005US6906182 Inhibiting abnormal cellular proliferation in a mammal; and a method of inhibiting replication of a virus in a mammal.
06/14/2005US6906031 Polyacid glycopeptide derivatives
06/09/2005WO2005051982A1 Glycopeptides and temperature-responsive micelles
06/09/2005WO2004087730A3 Method for producing diverse libraries of encoded polymers
06/08/2005EP1538156A1 Versatile linker compound and ligand, and method for preparation thereof
06/07/2005US6903070 Mixtures of peptide antibiotics and cyclodextrins used for prophylaxis of bacterial infections in humans
06/02/2005US20050118672 Using peptide: N-Glycosidase F (PNGase-F) to generate glycopeptide with uniform glycosylation patterns
06/01/2005EP1534316A2 Glycopeptide antibiotics and semisynthetic derivatives thereof and their use as antiviral agents
05/2005
05/31/2005US6900297 A compound which hybridizes with a nucleic acid includes multiple inked nucleosides (inlcudes a pentofuranosyl sugar portion and a base portion), and at least one sugar o-is terminated with R-N(R1a R1b) substitutent
05/26/2005US20050113561 Hydrochloride salts of a glycopeptide phosphonate derivative
05/26/2005US20050112563 Sub-sequences of 2'-deoxy-erythro-pentofuranosyl nucleotides that activate RNase H enzyme; diagnostics; antisense therapeutics
05/25/2005EP1532159A2 Scaffolded maleimide clusters for multivalent peptide assembly
05/19/2005WO2005044841A1 Method for preparing polyfunctionalized peptides and/or proteins via native chemical ligation
05/19/2005WO2005044197A2 Synthesis of glycopeptides with superior pharmacokinetic properties
05/19/2005WO2004094590A3 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
05/19/2005US20050106691 Process for the production of ramoplanin-like amide derivatives
05/19/2005US20050106658 Remodeling and glycoconjugation of peptides
05/19/2005US20050106598 Enhanced cellular uptake
05/19/2005US20050106563 Severe acute respiratory syndrome (SARS) coronaviral polypeptide for use in diagnosis, prevention and treatment of viral disease; viricides; genetic vaccines
05/19/2005CA2538005A1 Method for preparing polyfunctionalized peptides and/or proteins via native chemical ligation
05/18/2005CN1201817C Tumor CT antigen immune inducing agent for treating liver cancer and its prepn
05/12/2005WO2005042568A2 Hydrochloride salts of a glycopeptide phosphonate derivative
05/12/2005WO2004035605A3 Glycoprotein synthesis
05/12/2005US20050100982 Factor IX: remodeling and glycoconjugation of factor IX
05/12/2005CA2726967A1 Hydrochloride salts of a glycopeptide phosphonate derivative
05/10/2005CA2222995C Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides
05/06/2005WO2004090154A3 Acyl- phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis
05/05/2005US20050096261 Dna-binding polyamide drug conjugates
05/04/2005EP1527081A1 Glyconjugates comprising carbohydrate epitopes, methods for theirsynthesis, and their use for the treatment or prophylaxis of cancer
05/04/2005CN1612891A Process for producing modified peptide
05/04/2005CN1199989C Method for purifying teicoplanin by analog moving bed chromospheric separation
05/03/2005US6887976 Improved mammalian safety profile; glycopeptide phosphonate derivatives of invention unexpectedly exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammal; antibacterial agents
04/2005
04/28/2005WO2004064784A3 Composition and method for preventing or treating a virus infection
04/28/2005CA2542639A1 Novel heat shock protein 20-related polypeptides and uses therefor
04/27/2005CN1610692A Process for preparing glycopeptide derivatives
04/27/2005CN1609118A Cell wall acyl-alanyl-D-isoglutamine derivative and its prepn, medicine composition and use
04/21/2005WO2005035588A1 Synthetic polysaccharide antigens for immunological intervention in disease
04/21/2005WO2005034856A2 Targeted drug-formaldehyde conjugates and methods of making and using the same
04/21/2005WO2004041203A3 Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
04/21/2005WO2004041194A3 Inhibition of hiv-1 replication
04/21/2005CA2538418A1 Synthetic polysaccharide antigens for immunological intervention in disease
04/20/2005EP1355920A4 Extractive purification of lipopeptide antibiotics
04/12/2005US6878805 Peptide-conjugated oligomeric compounds
04/12/2005US6878686 Cross-linked glycopeptide-cephalosporin antibiotics
04/12/2005CA2131229C Bisconjugates comprising two saccharides and a spacer
04/07/2005US20050075483 Vancomycin derivatives linked with disaccharide sugar, obtained by deprotecting a protected glycopeptide, by sulfonation, replacement; preparing a glycopeptide by glycosylation of an aglycone derived from glycopeptide antibiotic
04/07/2005US20050074854 Glycosylated specificity exchangers
04/07/2005US20050074838 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
04/06/2005EP1520858A1 Process for producing sugar peptide having asparagine sugar chain and the sugar peptide
04/06/2005EP1326983B1 Gene cluster for ramoplanin biosynthesis
04/06/2005CN1195767C Antithrombotic compound
04/05/2005US6875755 Antithrombotic compound
03/2005
03/29/2005US6872701 Glycopeptide phosphonate derivatives
03/24/2005US20050064540 Glycoprotein remodeling using endoglycanases
03/17/2005WO2005023871A1 An agent for selective suppression disease-associated auto-reactive b-cells
03/17/2005WO2004075843A3 Glycosolated enkephalin agents
03/16/2005EP0716604B1 Thiol-derivatized nucleosides and oligonucleosides
03/10/2005WO2005005436A3 Cross-linked glycopeptide-cephalosporin antibiotics
03/03/2005WO2004091552A3 Biodegradable glucosaminemuramyl peptides for apoptosis modulation
03/03/2005US20050049197 Induction of immune response against desired determinants
03/01/2005US6861236 Harvesting antibiotic peptides comprising transport protein leader sequences
02/2005
02/24/2005WO2005016851A1 Recombined molecules and preparation thereof
02/24/2005WO2005016248A2 A novel antiproliferative factor and methods of use
02/24/2005US20050043507 Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysis
02/24/2005CA2530803A1 A novel antiproliferative factor and methods of use
02/23/2005EP1507798A1 Export and modification of (poly)peptides in the lantibiotic way
02/23/2005EP1507796A1 Cross-linked glycopeptide-cephalosporin antibiotics
02/23/2005CN1585778A Modified anti-TNF alpha antibody
02/22/2005US6858591 2-amino-3-hydroxy-3-uridyl-propanoic acid ester derivatives
02/22/2005US6858584 For therapy of bacterial disease in a mammal; side effect reduction
02/17/2005WO2004099135A3 Hiv prodrugs cleavable by cd26
02/17/2005WO2004087730A8 Method for producing diverse libraries of encoded polymers
02/17/2005US20050037950 N1-modified glycopeptides
02/16/2005CN1189477C Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition
02/15/2005US6855801 Peptides modulating activities of heparin other glycosaminoglycans or proteoglycans
02/10/2005WO2004083807A3 Methods of evaluating glycomolecules for enhanced activities
02/10/2005US20050032676 Administering lipidated glycopeptide antibiotic and cyclodextrin, reduced tissue accumulation of the glycopeptide antibiotic, reduced nephrotoxicity and reduced histamine release
02/10/2005US20050031584 Interleukin-2:remodeling and glycoconjugation of interleukin-2
02/08/2005CA2184183C Inhibin compositions and methods of use thereof
02/03/2005US20050026820 reducing nephrotoxicity; increased therapeutic window for the glycopeptide to allow a greater amount to be administered
02/03/2005US20050026818 Cross-linked glycopeptide-cephalosporin antibiotics
02/03/2005US20050026813 Antibiotic-metal complexes in the detection of gram-positive bacteria and other biological analytes
02/03/2005US20050025821 Lipid-comprising drug delivery complexes and methods for their production
02/03/2005CA2533849A1 Aminated complex-type sugar chain derivatives and process for the production thereof
02/01/2005US6849602 Compositions for alleviating neuropathic pain with prosaposin receptor agonists
01/2005
01/27/2005US20050020488 Process for preparing glycopeptide phosphonate derivatives
01/27/2005US20050019333 Glycosylated specificity exchangers
01/20/2005WO2005005436A2 Cross-linked glycopeptide-cephalosporin antibiotics
01/19/2005CN1568325A Cross-linked glycopeptide-cephalosporin antibiotics
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 34